Editor Profile

editor profile image is not found.

Dr. Manoj Kumar, M.Sc., M.Phil., Ph.D.

Associate Professor

Present

Jabalpur

India

Sukh Sagar Medical College and Hospital

editor profile QR Code is not found.

Dr. Manoj Kumar is Member of Indian immunology Society (ISS), Indian Society of Trauma and Acute (ISTAC) and International Society of Cellular Therapy (ISCT). He has done P.hD (2015) from All India Institute of Medical Sciences, New Delhi. M.Phil,  Ch. Charan Singh University, Meerut, India. His expertiseincludesTrauma, Sepsis, and Shock, hematopoietic Stem cells, and Immunology (cytokine analysis) patients with hemorrhagic shock, sepsis, and severe injury.

    No content available to display!!!
  • Kumar M, Anand K, Bhoi S. Mesenchymal stem cells –derived multivesicular bodies: Is it innovative novel cell-based therapeutic adjunct for trauma hemorrhagic shock patients?IP Indian J Immunol respire Med 2023; 8 (1): 37-38.
  • Kumar S, Choudhary N, Faruq M, Kumar A, Saran RK, Indercanti PK, Singh V, Sait H, Jaitley S, Valis M, Kuca K, Polipalli SK, Kumar M, Singh T, Suravajhala P, Sharma R, Kapoor S. Anastrozole-mediated modulation of mitochondrial activity by inhibition of mitochondrial permeability transition pore opening: an initial perspective. J Biomol Struct Dyn. 2023 Feb 23:1-17. doi: 10.1080/07391102.2023.2176927. Epub ahead of print. PMID: 36815262.
  • Ravikant, Kumari P, Kumar M, Roy P, Jeya M. Detection of Carbapenem-resistant Enterobacteriaceae by Real-Time PCR and Assessment of Hospitalization Related Risk Factors Associated with their Fecal Carriage: A Case-control Study. J Pure Appl Microbiol. Published online May 27, 2022. doi: 10.22207/JPAM.16.2.37.
  • Kumar M, Mondithoka S, Selvi A, Kamal VK, Mohanty S, Bhoi S, Trends in granulocyte colony-stimulating factor following trauma hemorrhagic shock, with manuscript number IJCIIS_2_20.
  • Narula S, Sharma P, Kumar N, Kumar N, Kumar M. An Upsurge of Gram Negative Bacteria in Community Acquired Pneumonia: An Alarming Trend!. J Emerg Med Forecast. 2018; 1(1): 1007.
  • Kumar M, Bhoi S, Keshava S, Resveratrol: Does Innovative Option for the Treatment of Mitochondrial Dysfunction among Trauma Hemorrhagic Shock? J Emerg Med Forecast. 2018; 1(1): 1005.
  • Kumar M, Mondithoka S, Bhoi S, Does G-CSFR Blocker Reduces Hematopoietic Dysfunction Among Trauma Associated Hemorrhagic Shock? 2020; 3(1): 1019. J Emerg Med Forecast. 2018; 1(1): 1005.
  • Kumar M, Bhoi S, Subramanian A, Kamal VK, Mohanty S, Rao D, et al. Evaluation of circulating haematopoietic progenitor cells in patients with Trauma Haemorrhagic shock and its correlation with outcomes. Int J Crit Illn Inj Sci 2016;6:56-60.
  • Kumar M, Bhoi S. Cell therapies for hematopoietic failure in trauma hemorrhagic shock. Clinical Management of Shock - The Science and Art of Physiological Restoration (ISBN 978-953-51-6519-4) (Submitted).